Arkolith/Insider Trading/AEON/Form 4

Grodnensky Oleg

10% OwnerAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed Jul 26, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2023Conversion(C)6.9M——6.9M
Jul 21, 2023Conversion(C)89K——7.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2023Conversion(C)6.9M——0
Jul 21, 2023Grant(A)5.3M——0
Jul 21, 2023Conversion(C)39K——39K
Jul 21, 2023Conversion(C)39K——39K
Jul 21, 2023Conversion(C)21K——21K
Jul 21, 2023Conversion(C)20K——20K
Jul 21, 2023Conversion(C)22K——22K
Jul 21, 2023Conversion(C)8K——8K
Jul 21, 2023Conversion(C)77K——77K

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950103-23-010810) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML